Quoin Pharmaceuticals Extends Exclusive Distribution Agreeme

Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton Syndrome - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

Turkey , Serbia , Malta , Georgia , United States , Azerbaijan , Macedonia , Moldova , Czech Republic , Kosovo , Montenegro , Hungary , Croatia , Slovenia , Albania , Kazal , Smolyan , Bulgaria , Poland , Cyprus , Romania , Greece , Czechia , Michael Myers , Company Annual Report On Form , Quoin Pharmaceuticals Inc , Quoin Pharmaceuticals Ltd , Partnership Agreements , Nasdaq , Company Or Quoin , Kim Gains Exclusive Rights , Six Additional Countries , Snow Covered , Quoin Pharmaceuticals , Distribution Agreement , Eastern Europe , Netherton Syndrome , North Macedonia , Chief Executive Officer , Kazal Type , Peeling Skin Syndrome , Palmoplantar Keratoderma , Epidermolysis Bullosa , Private Securities Litigation Reform Act , Annual Report , Resume , Careers , Uoin Pharmaceuticals Extends Exclusive Distribution Agreement With Er Kim For Its Lead Asset , Rx003 , Or Netherton Syndrome , Iospace , Advice ,